# OMEPRAZOLE AND SODIUM BICARBONATE
> **ANDA207476** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2016-12-06
## Drug
- **FDA Application Number:** ANDA207476
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OMEPRAZOLE AND SODIUM BICARBONATE
- **Generic name:** OMEPRAZOLE SODIUM BICARBONATE
- **Active ingredients:** OMEPRAZOLE; SODIUM BICARBONATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2016-12-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207476)
---
*AI Analytics · CC0 1.0*